TABLE 3.
Inhibition of K-Rta-mediated gene expression by RelAa
| Promoter | Fold activation
|
|
|---|---|---|
| K-Rta + vector (% CV) | K-Rta + RelA (% CV) | |
| ORF4 | 88.3 (9.3) | 2.3 (21.7) |
| ORF6 | 72.3 (17.8) | 6.0 (13.2) |
| ORF8 | 66.4 (15.3) | 1.4 (3.5) |
| ORF9 | 14.0 (12.6) | 2.8 (3.3) |
| K2 | 31.7 (14.6) | 3.8 (1.8) |
| ORF70 | 301.8 (11.5) | 9.0 (17.8) |
| K6 | 13.4 (8.0) | 8.4 (5.4) |
| K7 | 21.0 (0.9) | 4.6 (6.0) |
| ORF19 | 28.0 (8.2) | 4.3 (13.9) |
| ORF21 | 38.3 (22.6) | 3.2 (8.9) |
| ORF22 | 33.4 (24.6) | 18.3 (8.9) |
| ORF23 | 18.5 (21.2) | 3.5 (6.3) |
| ORF28 | 36.6 (16.8) | 14.7 (2.5) |
| ORF31 | 10.5 (6.3) | 7.2 (8.2) |
| ORF35 | 23.9 (7.0) | 3.1 (6.9) |
| ORF38 | 33.9 (5.6) | 1.4 (21.1) |
| ORF42 | 10.7 (12.5) | 2.6 (14.0) |
| ORF47 | 21.3 (6.3) | 3.7 (9.1) |
| K8 (K-bzip) | 209.5 (8.1) | 5.3 (6.8) |
| ORF52 | 10.8 (4.1) | 2.7 (19.4) |
| ORF57 | 265.1 (8.4) | 20.4 (8.9) |
| K9 | 15.2 (6.9) | 6.5 (7.4) |
| K10 | 12.5 (2.0) | 5.0 (7.5) |
| ORF59 | 288.3 (9.3) | 43.0 (5.2) |
| ORF61 | 76.00 (18.5) | 4.6 (7.1) |
| ORF64 | 16.4 (22.1) | 5.2 (5.0) |
| ORF67 | 21.8 (12.1) | 2.1 (0.5) |
| K12 | 99.2 (3.4) | 151.4 (6.6 |
| ORF73Ti | 65.6 (10.5) | 20.7 (13.9) |
| K14 | 193.7 (16.2) | 49.5 (19.4) |
| ORF75 | 15.3 (9.6) | 4.3 (1.8) |
| K15 | 30.4 (8.4) | 9.3 (4.8) |
| PAN | 288.9 (18.4) | 96.9 (4.7) |
| OriRNA | 37.3 (4.5) | 48.1 (6.7) |
a
The fold activation over the vector-transfected luciferase value is shown. The covariances (as percentages) of triplicate wells are also shown.